immatics biotechnologies GmbH (IMTXW) Stock Overview
Explore immatics biotechnologies GmbH’s financial performance, market position, analyst ratings, and future outlook.
immatics biotechnologies GmbH (IMTXW)
Key Financials
Key Financials
Market Cap
72.9K
P/E Ratio
-4.82
EPS (TTM)
N/A
ROE
-0.45%
IMTXW Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of immatics biotechnologies GmbH (IMTXW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of N/A.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.82 and a market capitalization of 72.9K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.